REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Hile Bio-Technology Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shanghai Hile Bio-Technology Co.,Ltd Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Hile Bio-Technology Co.,Ltd operates as a animal health products provider. The Company is engaged in epidemic prevention and produces product that care for the health and well being of farm animals and domesticated house pets. Shanghai Hile Bio-Technology's main business is the R&D, production, sales and service of veterinary vaccines. The Company was incorporated in 1981 and is headquartered in Shanghai China.

Headquarters
Room 1805, No. 138 Huaihai Middle Road, Huangpu District, Shanghai
Shanghai; Shanghai; Postal Code: 200021

Contact Details: Purchase the Shanghai Hile Bio-Technology Co.,Ltd report to view the information.

Basic Information
Total Employees:
Purchase the Shanghai Hile Bio-Technology Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Shanghai Hile Bio-Technology Co.,Ltd report to view the information.
Registered Capital:
Purchase the Shanghai Hile Bio-Technology Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Shanghai Hile Bio-Technology Co.,Ltd report to view the information.
Incorporation Date:
July 18, 1981
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
35.12%
Purchase this report to view the information.
4.99%
Purchase this report to view the information.
4.57%
Purchase this report to view the information.
4.19%
Purchase this report to view the information.
3.24%
Subsidiaries
Shandong Haili Biological Products Co., Ltd.
100%
Shanghai Caiyin Biological Technology Co., Ltd.
100%
Shanghai Jiemen Biotechnology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Hile Bio-Technology Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-10.37%▼
Total operating revenue
-28.38%▼
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-76.32%▼
Total assets
3.05%▲
Total equity
7.05%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-24.61%▼
Return on Equity (ROE)
-4.42%▼
Debt to Equity Ratio
2.04%▲
Quick Ratio
1.59%▲
Cash Ratio
-0.24%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai Jiaoda Onlly Co.,Ltd
 
Zhejiang Xinguang Pharmaceutical Co., Ltd.
Shanghai Zj Bio-Tech Co., Ltd
 
Shanghai Rightongene Biotechnology Co., Ltd.
Ocumension Therapeutics (Hong Kong) (欧康维视生物 (香港))
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo